DIERYNCK; INGE

Patent Applications and Registrations

Patent applications and USPTO patent grants for DIERYNCK; INGE.The latest application filed is for "mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance".

Company Profile

0.10.12

DIERYNCK; INGE - BERCHEM BE
Dierynck; Inge - Antwerpen BE
Dierynck; Inge - Antwerp BE
Dierynck; Inge - Wilrijk BE
Dierynck; Inge - B-2610 Wilrijk Bolgium BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mutational Profile In Hiv-1 Gag Cleavage Site Correlated With Phenotypic Drug Resistance App 20140127797 - DIERYNCK; INGE ; et al.	2014-05-08
Mutational profile in HIV-1 GAG cleavage site correlated with phenotypic drug resistance Grant 8,546,076 - Dierynck , et al. October 1, 2	2013-10-01
Lysine related derivatives as HIV aspartyl protease inhibitors Grant 8,318,779 - Jonckers , et al. November 27, 2	2012-11-27
Mutational Profile In Hiv-1 Gag Cleavage Site Correlated With Phenotypic Drug Resistance App 20120258448 - DIERYNCK; Inge ; et al.	2012-10-11
2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors Grant 8,202,887 - De Kock , et al. June 19, 2	2012-06-19
Fluorogenic enzyme substrates and methods of preparation Grant 7,863,428 - Dierynck , et al. January 4, 2	2011-01-04
Mutational Profile In Hiv-1 Gag Cleavage Site Correlated With Phenotypic Drug Resistance App 20100173282 - Dierynck; Inge ; et al.	2010-07-08
Crystal Structures Of Hiv-1 Protease Inhibitors Bound To Hiv-1 Protease App 20100173381 - SCHIFFER; Celia A. ; et al.	2010-07-08
2-(substituted-amino)-benzothiazole Sulfonamide Hiv Protease Inhibitors App 20090209583 - De Kock; Herman ; et al.	2009-08-20
Lysine Related Derivatives As Hiv Aspartyl Protease Inhibitors App 20090118339 - Jonckers; Tim Hugo Maria ; et al.	2009-05-07
Methods Of Assessing Hiv Integrase Inhibitor Therapy App 20070134766 - Vingerhoets; Johan Hendrika Jozef ; et al.	2007-06-14
Methods of assessing HIV integrase inhibitor therapy Grant 7,189,505 - Vingerhoets , et al. March 13, 2	2007-03-13
Fluorogenic enzyme substrates and methods of preparation App 20070037234 - Goeman; Jan Ludwig ; et al.	2007-02-15
Reporter molecules and methods for assaying the lipidations status of a cell Grant 7,129,036 - Van Acker , et al. October 31, 2	2006-10-31
Hiv integrase inhibitors App 20060211724 - Verschueren; Gaston Wim ; et al.	2006-09-21
Method of monitoring a biological system by labeling with an apo metal binding protein Grant 7,045,312 - Dierynck , et al. May 16, 2	2006-05-16
Methods of assessing HIV integrase inhibitor therapy App 20060029934 - Vingerhoets; Johan Hendrika Jozef ; et al.	2006-02-09
Methods of assessing HIV integrase inhibitor therapy Grant 6,958,211 - Vingerhoets , et al. October 25, 2	2005-10-25
Method of monitoring a biological system by labeling with an apo metal binding protein App 20050037341 - Dierynck, Inge ; et al.	2005-02-17
Method of monitoring a biological system by labeling with an apo metal binding protein Grant 6,800,437 - Dierynck , et al. October 5, 2	2004-10-05
Methods of assessing HIV integrase inhibitor therapy App 20030124514 - Vingerhoets, Johan Hendrika Jozef ; et al.	2003-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.